We help detect and treat heart disease and stroke.

The Technology

ArterioVision

MTI’s lead product, the CIMT (carotid intima-media thickness) test, or ArterioVision™, consists of standardized B-mode ultrasound image acquisition methodology and software that enables clinicians to safely and non-invasively screen for and monitor atherosclerosis (the underlying cause of heart attack and stroke) in individuals who are either asymptomatic or symptomatic for cardiovascular disease.

                    

      ArterioVision™ can accurately measure arterial CIMT.

NOTE: The terms CIMT, carotid IMT and  carotid intima media thickness are equivalent.

   




ęCopyright 2011 Medical Technologies International, Inc. All Rights Reserved
For more information Contact Us